Cardiology
Prevention
More in Prevention
Meta-analysis suggested lower stroke risk, but more definitive trial is not expected until 2032
Recent developments of interest in cardiovascular medicine
Health news and commentary gathered by ΒιΆΉ΄«Γ½ staff
Also in TTHealthWatch: beta-blockers after MI
Trial from China provides proof-of-concept for stroke risk reduction in symptomatic cases
Continued OAC failed to meet noninferiority in POPular PAUSE TAVI
Recent developments of interest in cardiovascular medicine
Trial paints a fuller picture of risk-benefit in complex patient population
Afib, hypertension, and others get updates with simplifications
More conclusive evidence for benefits on Afib burden, QoL
Bleeding reduced -- without risk of ischemic events -- versus dual antithrombotic in Korean trial
NOTION-3 trial informs care for those with severe AS and stable CAD
RESHAPE-HF2 has provocative implications for a wider pool of TEER candidates
